Raddella Holdings launches first biotech insulin manufacturing plant in Sri Lanka

Raddella Holdings introduce yet another revolutionary first with the launch of Sri Lanka’s first and only biotech insulin manufacturing plant. The recently concluded groundbreaking ceremony was held on September18, at the Koggala Export Processing Zone. The landmark event was attended by a host of dignitaries and guests including the State Minister of Pharmaceutical Production, Supply, and Regulation – (Prof.) Channa Jayasumana, Minister of Tourism – Prasanna Ranatunga, Minister of Plantation – (Dr.) Ramesh Pathirana, State Minister of Rural and School Sports Infrastructure Development – Thenuka Vidanagamage and many more.

The operation of the new plant will involve a joint venture between the Premium International Injectable Company (Pvt) Ltd, a subsidiary of Raddella Holdings and the State Pharmaceutical Manufacturing Corporation (SPMC). All new products manufactured as a result of this venture will be done under the SPMC brand name, with full government supervision.

The biotechnology manufacturing plant is a Rs. 3.5 billion, 100% local investment, which will employ over 200 specialized and highly trained professionals. All technology used in manufacturing will be state-of-the-art and conform to the highest tier of European standardization. This new plant has the capacity to meet 100% of projected local demand for next 15 years. The surplus produced thereafter will be exported and provide a valuable source of foreign revenue.

The new plant will utilize world famous SCADA systems to monitor and control the plant, all equipment, and the entire manufacturing process. This will guarantee the highest level of quality control, where all records of manufacture are completely automated and thus tamper-proof. Other quality control methods include adhering to the European Union Goods Manufacturing Practice (EUGMP), Good Manufacturing Practice (GMP), while also complying with the strict standards set by the World Health Organization (WHO).

The extensive planning for the plant happened over the last two years, in this time all designs, technology transfers, and specialist training have been completed, with all approvals and certification having been obtained. With construction completed soon, the plant will commence operations shortly.